CALGARY, May 19 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following submission to the U.S. Food and Drug Administration (FDA) for review, the Company is initiating a U.S. Phase I study of REOLYSIN(R) in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022). The principal investigator is Dr. Sanjay...
New agents improve survival time at high cost in metastatic colorectal cancer patients
HemOnc today
Posted May 6, 2010
New chemotherapeutic agents used to treat metastatic colorectal cancer were shown to have high costs associated with their survival benefits, although the costs fell below common estimates of willingness-to-pay amounts for a life-year.
Between 1996 and 2004, several chemotherapy agents were approved to treat patients with metastatic...
Cetuximab added to neoadjuvant chemotherapy enables life-saving surgery in patients with liver lesions linked to colorectal cancer, according to a report in The Lancet Oncology.
It says that while removal of colorectal liver metastases is a potential cure, the disease has traditionally been inoperable in up to 80% of patients.
But research now shows that neoadjuvant treatment with irinotecan or oxaliplatin-based...
National Cancer Institute
NCI Cancer Bulletin
September 22, 2009 • Volume 6 / Number 18
Many herbs, dietary supplements, and even vitamins are suspected of interfering with chemotherapy and radiation therapy, and doctors now routinely advise patients who are undergoing cancer treatment to avoid taking these products.
At the same time, cancer researchers have been intrigued by the potent and beneficial biological activity shown by some natural products...
New research details drug therapies in 2009 in Therapeutic Advances in Medical Oncology, published by SAGE
Los Angeles, London, New Delhi, Singapore and Washington DC (August 21, 2009) – Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival...
